Purchases and Sales Made in Q1 2024 in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during Q1 2024. The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-150K- 15.79% |
$8.31M - $10.9M
|
800K
$26.5M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-171K- 86.87% |
$9.45M - $12.4M
|
25.8K
$855K
|
|
|
May 15, 2024
Q1 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-225K- 36.0% |
$12.5M - $16.3M
|
400K
$13.3M
|
|
|
May 14, 2024
Q1 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-271K- 20.18% |
$15M - $19.7M
|
1.07M
$35.6M
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-306K- 70.32% |
$16.9M - $22.2M
|
129K
$4.28M
|
|
|
May 13, 2024
Q1 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-337K- 71.71% |
$18.7M - $24.4M
|
133K
$4.41M
|
|
|
May 15, 2024
Q1 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-348K- 42.33% |
$19.3M - $25.2M
|
474K
$15.7M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-360K- 13.98% |
$19.9M - $26.1M
|
2.21M
$73.4M
|
|
|
May 14, 2024
Q1 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-362K- 62.01% |
$20M - $26.2M
|
222K
$7.35M
|
|
|
May 15, 2024
Q1 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-362K- 92.11% |
$20.1M - $26.2M
|
31K
$1.03M
|
|
|
Aug 22, 2024
Q1 2024
|
Fiera Capital Corp
Montreal, A8 |
SELL
|
- |
-453K- 32.31% |
$25.1M - $32.8M
|
948K
$31.4M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-481K- 22.71% |
$26.7M - $34.9M
|
1.64M
$54.3M
|
|
|
Oct 07, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-1.01M- 94.94% |
$56.2M - $73.5M
|
54K
$1.79M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.46M- 47.12% |
$80.8M - $106M
|
1.64M
$54.3M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.46M- 47.12% |
$80.8M - $106M
|
1.64M
$54.3M
|
|
|
May 15, 2024
Q1 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.7M- 26.93% |
$94M - $123M
|
4.61M
$153M
|